PP ADVITOS GmbH Related News
An innovative device for multi-organ failure support
The ADVOS integrated 4-in-1 multi-organ support solution could dramatically improve survival rates of critically ill organ failure patients, including those with COVID-19.
Multi-organ failure (MOF)...
Organ support therapy ADVOS can effectively treat COVID-19 patients
A new study has demonstrated the efficacy of ADVOS organ support therapy in successfully treating COVID-19 patients.
ADVOS, the new blood purification procedure from ADVITOS,...
ADVITOS completes a €20m financing round
ADVITOS, a medical device manufacturer with a unique therapy for patients with multi-organ failure, has completed a €20m financing round led by Crédit Mutuel...
ADVOS multi-organ support to tackle multi-organ failure
The ADVOS – ADVanced Organ Support – therapy is the world’s first four-in-one treatment device providing multi-organ support for liver, kidney, lung and blood...